Efficacy of Chronic Disease Self-management Program in People With Schizophrenia

National Taipei University of Nursing and Health Sciences

Status: Completed

Conditions: Schizophrenia

Treatments: Other: Chronic disease self-management program; Other: General psychiatric intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT04503954

TCHIRB-10904004

Details and patient eligibility

About

This was a randomized controlled behavioral intervention trial to assess the efficacy of investigating program of chronic disease self-management program in people on schizophrenia patients conditions of depression, activities of daily living, social function, work, and quality of life.

Full description

Subjects were randomized to intervention group and control group. The primary outcome included eight measures, Stanford Self-Management Questionnaire, the Beck Depression Inventory-II, the Activities of Daily Living Rating Scale III, the Instrumental Activities of Daily Living Scale, the Participation Measure-3 Domains, 4 Dimensions, the Work Behavior Inventory, and the Schizophrenia-Quality of Life questionnaire.

Enrollment: 80 patients

Sex: All

Ages: 20 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of schizophrenia by DSM-5
• age > 20 years
• Stable mental symptoms
• Willing to sign the subject's consent

Exclusion criteria

• History of severe brain injury
• Substance abuse
• Diagnosis of intellectual developmental disorder
• Unable to follow instructions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

80 participants in 2 patient groups, including a placebo group

Self-management group

Experimental group

Description:

Self-management group Chronic disease self-management program is conduct training skills, person how to live together with personal chronic disease to make life quality better.

Treatment:

Other: Chronic disease self-management program

Control group

Placebo Comparator group

Description:

Control group will continue general psychiatric intervention.

Treatment:

Other: General psychiatric intervention